We have found that four taxanes with chemical modifications at positions C10 and C13 were active against all types of taxane resistant cell lines, resistant by p-Gp overexpression, by mutations in the β-tubulin binding site or by overexpression of the highly dynamic βΙΙΙ-tubulin isotype.
Introduction
One of the main problems in the chemotherapeutic treatment is the development of resistance to the compounds used. Although many tumours show a favourable response in the early stages of treatment, after exposure to the chemotherapeutic agents, the tumour often develops resistance to the treatment. Antitumour agents targeting tubulin have a great efficacy in the treatment of solid (paclitaxel, docetaxel, ixabepilone) or blood (vinblastine, eribulin) cancers, [1] [2] [3] however, their highly systemic toxicity compromises the treatments based on these agents. Nevertheless, these compounds have also an advantage over the kinase inhibitors. [4] [5] Since they block tubulin which is involved in several essential cell functions and is a major constitutive protein, there is no possible alternative pathway to substitute the functions of tubulin (the main reason for the development of resistance against kinase inhibitors [6] [7] ). Thus, resistance through alternative pathways is not possible in the case of these compounds.
Resistance to antitumoral agents targeting tubulin is possible through three different mechanisms: One of the membrane pumps usually involved in resistance to taxanes is pGlycoprotein (p-Gp), a protein involved in detoxification mechanism. It is assumed that its major role is to restrict the entrance of toxics through the gastrointestinal track or to prevent their access from blood stream to fetus and sensitive organs such as brain and testis. 9 In cells overexpressing p-Gp, two opposite mechanisms control the intercellular concentration of drug, i.e., p-Gp decreases the internal concentration of a drug to reduce its effective cytotoxicity, but on the other hand, the target protein binds to a drug with high affinity to accumulate the drug inside the cell. The effectiveness of these resistance mechanisms depends on the relative affinity of a drug to p-Gp and the target. An increased affinity to the target or a decreased affinity to p-Gp will overcome p-Gpmediated resistance. 10 The effect of variations in the affinity of taxanes on the resistance level of p-Gp overexpressing cells have been previously studied in our group and reported. [10] [11] These studies have shown that very high affinity taxanes (chitax-40) are able to overcome pGp-mediated resistance. The same effect has been observed for other compounds which bind covalently to tubulin. [12] [13] [14] Second-generation taxanes with modifications at C2, C3'N and C10 positions have also been shown to be extremely effective against cells resistant to taxanes by pGp overexpression. [15] [16] [17] Although there were previous studies on the relation of changes in the taxane structure with their biological activities, [18] [19] measurements of the microtubule-taxane binding affinities have been performed only recently, which allows a rigorous examination of the relationship between binding affinity and cytotoxicity in drug-sensitive cells and drug-resistant cells overexpressing p-Gp. 10, [20] [21] The study of the relationship between binding affinity and cytotoxicity ( Figure 5 ) by Matesanz et al. in 2008 10 indicates that there are factors that modulate the cytotoxicity in cells although both variables are related, i.e., there are compounds showing cytotoxicities on sensitive cells higher than expected from their binding affinity (paclitaxel, docetaxel, chitax-18), while some compounds exhibit higher cytotoxicity on resistant cells than those predicted from their binding affinity (chitax-19, chitax-21, chitax-35).
The second way that tumour cells resists paclitaxel and its derivatives is by changing their tubulin. Although it is difficult for human cells to mutate in response to a chemical agent, it is possible for them to use the genetic diversity of the tubulin isotypes to reduce its sensitivity to certain compounds. Most vertebrate isotypes fall into six categories, i.e., βI, βII, βIII, βIV, βV and βVI, 22 with most of the differences in the clusters 124-129 and 237-240, as well as the C-terminal sequence. Although all 6 isotypes are able to carry out two of the three canonical functions of microtubules (forming the mitotic spindle and the interphase network), the strong conservation of the tubulin isotypes implies that they should have specific individual functions. From these isotypes, βΙΙΙ is the one mostly involved in resistance to chemotherapy. βIII differs from the other main tubulin isotypes, βI, βII, and βIV, with the changes S126C and C241S, and in the presence of a lysine and a phosphorylated serine at the C-terminal. 23 βII, βIII, βIV isotypes have been isolated from bovine brain 24 and it was found that the properties of the αβIII dimer differs significantly from the other two in the binding of several microtubule modulating agents. 25 It was also found that the αβIII microtubules are less prone to inhibition of their dynamic behavior by docetaxel. 26 Cells overexpressing βIII tubulin are resistant to paclitaxel, 27 and it is known that high levels of βIII tubulin are found in docetaxel-resistant tumors. Thus, overexpression of βIII tubulin is an important prognosticator for the development of drug resistance. [28] [29] [30] [31] There are different hypotheses to explain the molecular basis of paclitaxelresistance due to overexpression of βIII tubulin. Two plausible explanations are: (a) αβΙΙΙ dimers are the ones that are most dynamic, 26 so that the cell compensates for the decrease in dynamics due to microtubule-stabilising agents by increasing the amount of these dimers, and (b) there are small but critical differences in the pore type I site (the initial external site for the binding of microtubule-stabilising agents on their way to the luminal site) between βI and βIII tubulins. 12, 32 Some difference in the pore type site I should result in a lower binding affinity to the initial pore site and then much lower internalization rate towards the inner site 33 , which may cause weakening of microtubule stabilisation.
Finally, it has been observed that mutations in β-tubulin rapidly appear at the paclitaxel or laulimalide binding sites [34] [35] [36] in cell cultures exposed to microtubulestabilizing agents, which suggests that a mutational mechanism of resistance is possible.
However, despite early reports on the relevance of tubulin mutations in patients with non-small cell lung carcinoma, 37 sequencing of tumors does not show any evidence that β-tubulin mutations could play a major role in the resistance of tumors to taxanes. [38] [39] [40] [41] [42] [43] [44] Nevertheless, a few mutations 41, [45] [46] have been found to result in effective resistance of the mutated cells to paclitaxel. 47 This finding indicates that these mutations can play an effective role in some specific cases and thus drugs that are effective against tumors mutated in the β-tubulin gene could be of clinical interest.
In this paper we investigate the reasons for the effectiveness of a series of modified taxanes previously reported to be highly effective on p-Gp-overexpressing cells 15, 16, 17 by performing complete characterizations of their cellular effects, as well as their interaction with microtubules. These characterizations include the assessment of the NMR, thermodynamic and biochemical parameters of the microtubule assembly, and the analysis of the structural effects of these taxanes on microtubules using small angle X-ray scattering.
Materials and Methods

Ligands and chemicals
Chitax-4 and chitax-40 were synthesized as previously reported. 10 SB-T-1102, SB-T-1214, SB-T-12854 and SB-T-121303 were synthesized using the methods previously reported. [15] [16] [17] Flutax-2 was synthesized as previously described. 48 Epothilone B was a kind gift from Prof. Karl-Heinz Altmann (ETH, Zürich). The rest of the chemicals employed were commercially available with analytical grade or better.
Human cell methods.
Cytotoxicity evaluation was performed with A2780, A2780AD, (overexpressing p-Gp) 49 , PTX10, PTX22, A8 (A2780-derived) 50 human ovarian carcinoma cell lines, Hela and Hela βIII transfected cells 51 with the MTT assay modified as previously described.
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Indirect immunofluorescence was performed in A549 cells 52 that had been cultured overnight in 12 mm round coverslips and incubated further for 24 h in the absence (drug vehicle: DMSO) or in the presence of different ligand concentrations.
Attached cells were permeabilized with Triton X100 and fixed with 3.7%
formaldehyde. Microtubules were specifically stained with DM1A α-tubulin monoclonal antibodies and DNA with Hoechst 33342 as previously described. 53 The preparations were examined using a Zeiss axioplan epifluorescence microscope and the images were recorded in a Hamamatsu 4742-95 cooled CCD camera. Cell cycle analysis was performed as previously described.
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Tubulin preparation and tubulin assembly induction measurements.
Calf brain tubulin was purified as described in the literature. 55 Glutaraldehydestabilized microtubules with active paclitaxel binding sites were prepared as described. 32 Critical tubulin concentrations of tubulin in PEDTA4-GTP (10 mM sodium phosphate, 1 mM EDTA, 4 mM MgCl 2, 1 mM GTP, pH 6.7) in the presence of ligands were measured as previously described. 54 The polymers formed were adsorbed onto formvar/carbon coated copper grids, stained with 1% uranyl acetate, and observed with a JEOL 1230 electron microscope operated at 100 kV and equipped with a Gatan
Bioscan 702 CCD camera.
Binding of taxanes to unassembled tubulin and microtubules.
The binding constants of SB-T-1102, SB-T-1214 and SB-T-12854 were measured as previously described. 56 To measure the binding affinity of SB-T-121303, 1 Bruker AVANCE 500 MHz spectrometer as previously described.
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STD and TR-NOE experiments were performed also as previously described 59 .
Conformational search and docking of ligands.
The paclitaxel derivative structures were built from the paclitaxel template based on electron crystallography and NMR TR-NOESY experiments. 60 The internal binding site structure was taken from 1JFF, 61 while the external binding site used the one previously reported by us. 60 The βIII binding site was constructed by homology modeling from 1JFF. SB-T-1102, SB-T-1214, SB-T-12854, SB-T-121303 and paclitaxel were docked in both the internal and external sites of microtubules as previously described. 60 Structures located in the internal site were minimized using 
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The predicted STD values of each structure were obtained with CORCEMA-ST and the structure of lowest energy value of these 100 structures was considered for comparison against the experimental data.
X-ray scattering measurements.
Tubulin was equilibrated in 10 mM sodium phosphate buffer with 1 mM EDTA and 0.1 mM GTP at pH 7.0 through a Sephadex G-25 medium column (25x9 mm), and the protein was centrifuged for 20 min at 90,000xg in a TLA120.2 rotor in a Optima TLX centrifuge (Beckman) to remove aggregates. The tubulin concentration was then determined spectrophotometrically as previously described. 58 MgCl 2 (7 mM) and up to 1 mM GTP were added to the sample (final pH 6.7) and the desired ligand or DMSO (vehicle) in a 10% stoichiometric excess over the protein concentration was added. The samples were incubated for 20 min at 37 ºC and kept at 25 ºC before recording the scattering patterns.
SAXS data collection was performed on a Bruker NANOSTAR system coupled to an X ray tube (λ = 1.54Å), wherein the camera was set to cover the scattering vector range, defined as reciprocal Bragg spacing i.e. s = 2 sin θ/λ, from 0.013 to 0.22 nm
Calibration of the scattering vector was obtained by reference to the orders of diffraction of silver behenate. 67 The temperature of the samples was set to 25 ºC and the X-Ray scattering profile was recorded for 2 h in 30-min frames with a Bruker Hi-Star multiwire area detector. Data analysis was performed using the Bruker software provided or the FIT2D software package provided by ESRF (http://www.esrf.eu/computing/scientific/FIT2D/). Raw data were normalized for the incoming intensity and detector response before averaging and subtracting the buffer scattering pattern. Time frames in which the data significantly differed from the original pattern due to radiation damage were removed before averaging.
The low angle X-ray scattering pattern of microtubules in solution can be described as the Fourier transform of a hollow cylinder. To a first approximation, the intensity is given by the zero'th order Bessel function , q being the scattering
J qR angle and R, the cylinder radius. 68 The position of the first scattering maximum is therefore a sensitive measure for the radius of the microtubule, via relation J 01 = (1.22/2R), since these are not distorted in a solution scattering pattern due to overlap between the higher order diffraction maxima of the helical lattice [69] [70] The differences in diameter between microtubules assembled in the presence of different taxanes can be interpreted, to a good approximation, as changes in the average number of protofilaments making up the cylinder wall.
RESULTS
Cell biology
In order to have a rigorous comparison between the cytotoxicity of the compounds and those previously determined, 10 the compounds were tested for their cytotoxicity under the same conditions against the same cell lines (Table I) . The compounds showed a very good activity on A2780AD cells (resistant to paclitaxel by the MDR mechanism), hence confirming all previous results.
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Then, we wanted to know if the compounds were also effective in cells resistant to paclitaxel by other mechanisms (mutations in the β-tubulin binding site and overexpression of βIII-tubulin isotype). The compounds showed a very good activity in cells overexpressing βIII-tubulin isotype (Table II) (Table III) .
The results are fully compatible with those previously published for p-Gpoverexpressing cells and indicate that these taxanes are able to overcome resistance by all known mechanisms. It is worth mentioning that the compounds do not have a large increase in cytotoxicity as compared to paclitaxel (in fact they are less cytotoxic than paclitaxel in the A2780 and Hela non-resistant cells). This is compatible with previously reported results, 10 which indicate that a minimal amount of ligand molecules should be bound to the cellular microtubules to produce the cytotoxic effect. Thus, the drug concentration should be over a certain minimum which is the minimal IC 50 that can be measured with the method employed. As shown in Figure 5A of Matesanz et al., are extremely effective in increasing the rate of microtubule assembly. In the presence of these taxoids the assembly rate (even in the absence of GTP in the media) is dramatically greater than that in the presence of paclitaxel or GTP.
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Also, the assembly proceeds without an appreciable induction period and is complete within 2 min. Since the assembly induction in this work [16] [17] was monitored by turbidity and this technique was affected by the morphology of the polymers, we wanted to know if the effect of these compounds on the microtubule assembly was limited to an increase in the rate of the assembly or if it also increased the mass of polymer formed. Thus, we tested the critical concentrations of tubulin required for assembly induction in the presence of the compounds using centrifugation and quantification of the polymer formed. All ligands induced tubulin assembly with much higher potency than paclitaxel and docetaxel, indicating that not only the rate of assembly was faster but also more polimer was formed (Table IV) .
Binding constant and thermodynamic parameters of the binding of the compounds to microtubules and dimeric tubulin.
In order to correlate the observed cytotoxic effect of the compounds with their affinity constant to microtubules, the binding constants of SB-T-1102, SB-T-1214 and SB-T-12854 at different temperatures were measured using the flutax-2 displacement method 54, 56 ( Table V) . Since the binding constant of SB-T-121303 exceeded the sensitivity of the flutax-2 displacement test, 57 its affinity constant was obtained using the epoB displacement method 10 (Table V) .
Using the binding affinity data, the thermodynamic parameters of the interaction, i.e., free energy of the binding (∆G) and the enthalpy (∆H) and entropy (∆S) contributions to ∆G (Table VI) , could be calculated.
The effect of single substituent changes on the binding affinity of the compounds could easily be quantified. The change at C13, which eliminated the aryl group at position C3' and introduced an isobutyl moiety resulted in no change in the binding affinity, i.e., SB-T1102 (2.4±0.3x10 It is difficult to know the exact contribution of the structural changes on the binding affinity because there are at least two differences between the compounds and any other taxanes analyzed, but if we consider the differences in binding energy to the paclitaxel site, the effect of the modifications at C10 appears to be negligible. 10 The observed effects of structural changes on binding affinity can be quantified as follows: ligands cannot be studied with these techniques).
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Both the TR-NOESY spectra of the compound bound to microtubules which would provide the bioactive conformation ( Figure 3A ) and the STD spectra which would provide the binding epitope ( Figure 3B) were obtained, although the signals obtained were of low intensity, as expected from a compound with a high affinity to the target and thus with slow dissociation kinetics.
The TR-NOESY data showed clearly cross peaks between the benzoyl protons at ortho position with respect to the esther group and the tert-butyl protons of the side chain, indicating that the bound conformation is essentially identical to that previously determined for docetaxel 10 and thus this conformation could be used to build the structures of the taxanes examined.
NMR-guided modeling of the bioactive conformations.
The STD and TR-NOESY data were then employed to derive a detailed 3D model for the tubulin-bound conformations of the ligands. Although the intensities of the cross peaks were weak, the STD information obtained allowed us to model SB-T-12854 into the pore binding site as previously described. 59 NRMSD of the STD fitting was 14.4%, which is excellent and indicates that the compound fits in the pore binding site in the same way as docetaxel does ( Figure 4A ).
Considering that the conformation and fitting in the pore binding site are identical to those described for docetaxel, it is reasonable to hypothesize that the interaction of the compounds with tubulin may be essentially identical to that previously described. 59 The taxanes in this study were thus docked into the binding site and the Effect on microtubule structure.
In order to examine the effect of the compounds on microtubule structure, the diameter of the ligand-induced microtubules was measured using SAXS. 60, [69] [70] The size of all induced microtubules ( Figure 5 ) were between those of paclitaxel and docetaxel, with an average number of protofilaments ranging between 13.2 (SB-T-1214) and 13.9
(SB-T-12854) (Table VII) .
In a previous paper 60 we reported that the diameter of taxane-induced microtubules was dominated by the substituents at C7 and C10. We have observed that bulky groups at C7 increase the number of protofilaments of microtubules, while bulky groups at C10 decrease the number of protofilaments. However, modifications at C13
have little or no effect on microtubule structure, while the introduction of an azide group at the meta position of the phenyl ring at C2 slightly increases the microtubule diameter.
All the compounds examined have small substituents at C10 and subsequently induce microtubules with smaller diameter than that of docetaxel, which does not have substituents at C7 and C10. Also, as expected from the introduction of the methoxy group at C2, SB-T-121303 induced the microtubules with the largest diameter observed.
However, none of the taxanes studied induced a major modification in the structure of the microtubules, which indicates that the effect on the structure is not the cause of the higher activity observed. Nevertheless, the fact that the changes in the structures reflect the same pattern as those previously reported 10 reinforces the hypothesis that the interaction of the compounds with the binding site is essentially the same as that of other taxanes.
Discussion
We have studied the differences in the cellular effects and the interaction with microtubules for a series of taxanes highly active in MDR cells, with the intention to unveil the characteristics that result in the ability to overcome all known mechanisms employed by tumour cells to resist taxanes (p-Glycoprotein-mediated multidrug resistance, mutations in the taxane binding pocket at β-tubulin, and βIII tubulin isotype overexpression).
Celular and biochemical differential effects of the SB-T compounds. Structural
basis for the higher assembly induction power. Concerning the biochemical parameters of the taxane-site interaction, the two main significant differences observed are the higher assembly induction power as compared with classical and other high affinity taxanes (as expected from the cellular results), and the higher entropic contribution to the free energy of binding.
From the comparison of the entropy changes of taxane-binding previously obtained, 10 it has been found that the entropy change in the binding process is determined by two parameters, i.e., the hydrophobicity of the ligand and the molecular volume which determines the entropy of the bound ligand. When the volume of a certain side chain is decreased and the functional group incorporated has more sp 3 carbons, the conformational freedom of the side chain increases which leads to the increase in the entropy of the bound species. This is the case for all the SB-T compounds examines, in which the phenyl moiety at the C13 side chain has been replaced with an aliphatic side chain, which justifies the higher entropic contribution to the free energy of binding. is the one with the lowest affinity (similar to paclitaxel) and also with the lowest assembly induction power (although still significantly higher than that of paclitaxel). In this case, the structural differences with paclitaxel are in the C13 side chain which has aliphatic groups instead of aryl moieties, while the group at C10 is an acetyl group that is same as that in paclitaxel. The main visible difference in the binding site is the slight rotation of the ligand which disrupts the H-bond with R284, inducing a different conformation to the M-loop. The same effect is observed in the more powerful ligands, SB-T-1214 ( Figure 4C ) and SB-T-12854 ( Figure 4D ), in which a bulkier substituent at C10 points toward the luminal space of the microtubule. The last ligand, SB-T-121303
( Figure 4F ), has the highest binding affinity, but is not the one with the highest assembly induction power. In this case, the binding pose is dominated by the interaction of the methoxy group at the meta position of the benzoyl group at C2 with H229, as in the case for chitax -40, 60 wherein the interaction with R284 is also formed, but the Mloop has the same conformation as that in the presence of paclitaxel.
From the data available, we propose that the enhancement of the tubulin assembly power is caused by (i) the different interactions of the compounds with the Mloop, resulting in higher potencies in the absence of the interaction with R284, and (ii)
by the higher binding affinity to the site (in the case of SB-T-121303), as observed in the cases for other MSAs (Figure 4 ). 54 The compounds that do not interact with R284
(SB-T-1102, SB-T-1214 and SB-T-12854) have much higher assembly induction potency than the classical taxanes, as well as high-affinity taxanes (chitax-4 and chitax-40), although these compounds have affinities to the binding site similar to that of paclitaxel. SB-T-121303, with 50 times higher binding affinity by interacting with R284, is significantly less potent in inducing microtubule assembly than SB-T-12854.
Rationalization of the effect of the compounds on resistant cells.
How could these changes observed be related to their effect on resistant cells?
From the view point of the p-Gp-mediated multidrug resistance, which is not tubulin mediated, the effect can only be ascribed to either an increase in affinity to tubulin (high affinity compounds or covalent binders to tubulin are able to overcome p-Gp-mediated MDR in tumoural cells 10, 12, 75 ) or to a decrease in affinity to the membrane efflux pump.
The former cannot be the case, because the effects of SB-T-1102, SB-T-1214 and SB-T-12854 have similar or only slightly higher binding affinities than paclitaxel and docetaxel, except for the case of SB-T-121303, which has a very high affinity to tubulin due to the meta-methoxy group in the C2 benzoyl moiety.
Lower R/S ratios have been previously observed for other medium-affinity (Ka and high levels of βIII tubulin are found in docetaxel-resistant tumors. [28] [29] [30] [31] However, there are no differences in the paclitaxel-binding site between βI (the major isotype) and βIII, the only changes observed there are S227A and C241S close to the binding site. These changes should result in a global change in the binding site, i.e., slightly displacing the global volume of the binding site towards the east ( Figure 6 ).
This change is due to the loss of the H-bonds formed between S277 and S280, as well as Q281 and a small opening of the loop directly in contact with the α-subunit due to the C241S mutation. This increase in space affects the position C13 in particular with the phenyl ring being displaced 2.5 Å towards the east inside a larger binding pocket ( Figure 6 ). This change should increase the desolvation energy for classical taxanes, decreasing their affinity. The effect can be compensated with an increase in affinity, since from the cytotoxicity data, high affinity compounds are able to overcome the resistance due to βIII-overexpression (chitax-4 and chitax-40). However the SB-T compounds studied are more effective in these cells than the chitax compounds with much higher affinity. The reason for this should be the larger entropic freedom of the side chain, which increases the entropy of the bound state and compensates the increase 
